Patent · US Active

Inhibitors of cysteine proteases and methods of use thereof

US8173696B2 · kind B2 · utility

2Cited by
0References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 13, 2008
Grant dateMay 8, 2012
Priority date
Expiry dateNov 27, 2030

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention relates to semicarbazone or thiosemicarbazone inhibitors of cysteine proteases and methods of using such compounds to prevent and treat protozoan infections such as trypanosomiasis, malaria and leishmaniasis. The compounds also find use in inhibiting cysteine proteases associated with carcinogenesis, including cathepsins B and L.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.